Irish Life Investment Managers’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Irish Life Investment Managers’s Portfolio MACK Stock Details MACK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$25.6K	Buy	+483	New	+$21.2K	﹤0.01%	1807

Other funds holding MACK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Irish Life Investment Managers's MACK Position: Q2 2013 in Review

Irish Life Investment Managers opened a new position in Merrimack Pharmaceuticals, Inc. (MACK) in Q2 2013: 483 shares worth $25.6K. The stake represents ﹤0.01% of the portfolio and ranks #1807 among its holdings.

89 funds tracked by Wall St. Rank hold MACK as of Q2 2013.

Irish Life Investment Managers held 483 shares of Merrimack Pharmaceuticals, Inc. worth $25.6K as of Q2 2013.
Merrimack Pharmaceuticals, Inc. was a new Irish Life Investment Managers position in Q2 2013.
Merrimack Pharmaceuticals, Inc. made up ﹤0.01% of Irish Life Investment Managers's portfolio in Q2 2013, its #1807 holding.
89 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q2 2013.

Based on Irish Life Investment Managers's 13F filing for Q2 2013, filed 13 Aug 2013.